undefined

Julian Hoffman

Expert discussing the biotech sector, potential M&A deals, and the performance of weight-loss drug companies like Novo Nordisk and Eli Lilly.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app